Clinical trials

Condition   Drug Name  
Study Pimecrolimus in vitiligo
Design Open
Patients 22
Treatment Regimen Pimecrolimus 1% ointment top. b.i.d.
Conclusions Pimecrolimus was safe and effectively induced repigmentation in patients with vitiligo
Reference(s) Topical pimecrolimus in vitiligo - A preliminary study
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-97.
Author and Affiliation Kanwar, A.J.